Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,722 | -3,755 | -1,727 | -8,162 | -6,374 |
| Depreciation Amortization | 157 | 106 | 53 | 213 | 160 |
| Accounts receivable | N/A | 282 | 122 | -115 | N/A |
| Other Working Capital | -845 | -661 | -59 | -337 | -726 |
| Other Operating Activity | 1,731 | 44 | 3 | 634 | 952 |
| Operating Cash Flow | $-5,679 | $-3,984 | $-1,608 | $-7,767 | $-5,988 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $0 | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 232 | N/A | N/A | 13,155 | 4,361 |
| Other Financing Activity | -137 | -137 | -137 | -884 | -265 |
| Financing Cash Flow | $95 | $-137 | $-137 | $12,271 | $4,097 |
| Beginning Cash Position | 10,743 | 11,076 | 11,076 | 6,572 | 6,572 |
| End Cash Position | 5,159 | 6,955 | 9,331 | 11,076 | 4,680 |
| Net Cash Flow | $-5,585 | $-4,121 | $-1,745 | $4,504 | $-1,892 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,679 | -3,984 | -1,608 | -7,767 | -5,988 |
| Free Cash Flow | -5,679 | -3,984 | -1,608 | -7,767 | -5,988 |